nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—osteoarthritis—Prednisone—systemic lupus erythematosus	0.194	0.5	CpDpCtD
Sulindac—osteoarthritis—Methylprednisolone—systemic lupus erythematosus	0.194	0.5	CpDpCtD
Sulindac—PTGS2—systemic lupus erythematosus	0.109	0.529	CbGaD
Sulindac—ALB—systemic lupus erythematosus	0.0968	0.471	CbGaD
Sulindac—PTGS2—Dapsone—systemic lupus erythematosus	0.0317	0.149	CbGbCtD
Sulindac—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0275	0.129	CbGbCtD
Sulindac—PTGS1—Dapsone—systemic lupus erythematosus	0.0268	0.125	CbGbCtD
Sulindac—PTGS2—Betamethasone—systemic lupus erythematosus	0.0236	0.111	CbGbCtD
Sulindac—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0174	0.0812	CbGbCtD
Sulindac—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0168	0.0787	CbGbCtD
Sulindac—SLC22A6—Cyclosporine—systemic lupus erythematosus	0.0154	0.0723	CbGbCtD
Sulindac—ALB—Prednisone—systemic lupus erythematosus	0.0139	0.065	CbGbCtD
Sulindac—PTGS2—Dexamethasone—systemic lupus erythematosus	0.0137	0.0643	CbGbCtD
Sulindac—CYP1A1—Dexamethasone—systemic lupus erythematosus	0.0116	0.0543	CbGbCtD
Sulindac—SLC22A6—Methotrexate—systemic lupus erythematosus	0.00817	0.0383	CbGbCtD
Sulindac—ALB—Methotrexate—systemic lupus erythematosus	0.00696	0.0326	CbGbCtD
Sulindac—AKR1B1—blood plasma—systemic lupus erythematosus	0.00262	0.0649	CbGeAlD
Sulindac—MAPK3—endothelium—systemic lupus erythematosus	0.00214	0.053	CbGeAlD
Sulindac—MAPK3—blood plasma—systemic lupus erythematosus	0.0019	0.0471	CbGeAlD
Sulindac—PTGDR2—tendon—systemic lupus erythematosus	0.0018	0.0447	CbGeAlD
Sulindac—AKR1B1—connective tissue—systemic lupus erythematosus	0.00139	0.0346	CbGeAlD
Sulindac—AKR1B1—nephron tubule—systemic lupus erythematosus	0.00135	0.0335	CbGeAlD
Sulindac—AKR1B1—kidney—systemic lupus erythematosus	0.00119	0.0294	CbGeAlD
Sulindac—AKR1B1—cortex of kidney—systemic lupus erythematosus	0.00116	0.0287	CbGeAlD
Sulindac—CYP1A2—urine—systemic lupus erythematosus	0.00114	0.0283	CbGeAlD
Sulindac—AKR1B1—lymphoid tissue—systemic lupus erythematosus	0.00102	0.0253	CbGeAlD
Sulindac—MAPK3—connective tissue—systemic lupus erythematosus	0.00101	0.0251	CbGeAlD
Sulindac—MAPK3—nephron tubule—systemic lupus erythematosus	0.000978	0.0243	CbGeAlD
Sulindac—AKR1B1—tendon—systemic lupus erythematosus	0.000958	0.0238	CbGeAlD
Sulindac—AKR1B1—bone marrow—systemic lupus erythematosus	0.000928	0.023	CbGeAlD
Sulindac—MAPK3—skin of body—systemic lupus erythematosus	0.000912	0.0226	CbGeAlD
Sulindac—MAPK3—kidney—systemic lupus erythematosus	0.00086	0.0213	CbGeAlD
Sulindac—AKR1B1—lung—systemic lupus erythematosus	0.00084	0.0209	CbGeAlD
Sulindac—MAPK3—cortex of kidney—systemic lupus erythematosus	0.000837	0.0208	CbGeAlD
Sulindac—PPARD—lymphoid tissue—systemic lupus erythematosus	0.000801	0.0199	CbGeAlD
Sulindac—AKR1B1—nervous system—systemic lupus erythematosus	0.000778	0.0193	CbGeAlD
Sulindac—PPARD—tendon—systemic lupus erythematosus	0.000753	0.0187	CbGeAlD
Sulindac—AKR1B1—central nervous system—systemic lupus erythematosus	0.000749	0.0186	CbGeAlD
Sulindac—SLC22A6—nephron tubule—systemic lupus erythematosus	0.000748	0.0186	CbGeAlD
Sulindac—MAPK3—lymphoid tissue—systemic lupus erythematosus	0.000738	0.0183	CbGeAlD
Sulindac—MAPK3—tendon—systemic lupus erythematosus	0.000694	0.0172	CbGeAlD
Sulindac—MAPK3—bone marrow—systemic lupus erythematosus	0.000672	0.0167	CbGeAlD
Sulindac—PPARD—lung—systemic lupus erythematosus	0.000661	0.0164	CbGeAlD
Sulindac—SLC22A6—cortex of kidney—systemic lupus erythematosus	0.000641	0.0159	CbGeAlD
Sulindac—PPARD—nervous system—systemic lupus erythematosus	0.000612	0.0152	CbGeAlD
Sulindac—MAPK3—lung—systemic lupus erythematosus	0.000609	0.0151	CbGeAlD
Sulindac—CYP1A2—blood plasma—systemic lupus erythematosus	0.000595	0.0148	CbGeAlD
Sulindac—PPARD—central nervous system—systemic lupus erythematosus	0.000589	0.0146	CbGeAlD
Sulindac—PTGS1—endothelium—systemic lupus erythematosus	0.00058	0.0144	CbGeAlD
Sulindac—MAPK3—nervous system—systemic lupus erythematosus	0.000564	0.014	CbGeAlD
Sulindac—PTGS2—endothelium—systemic lupus erythematosus	0.000555	0.0138	CbGeAlD
Sulindac—MAPK3—central nervous system—systemic lupus erythematosus	0.000543	0.0135	CbGeAlD
Sulindac—PTGS1—blood plasma—systemic lupus erythematosus	0.000516	0.0128	CbGeAlD
Sulindac—PTGS2—blood plasma—systemic lupus erythematosus	0.000493	0.0122	CbGeAlD
Sulindac—CYP1A1—skin of body—systemic lupus erythematosus	0.000282	0.007	CbGeAlD
Sulindac—PTGS1—connective tissue—systemic lupus erythematosus	0.000274	0.00681	CbGeAlD
Sulindac—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000267	0.159	CbGdCrCtD
Sulindac—CYP1A1—kidney—systemic lupus erythematosus	0.000266	0.0066	CbGeAlD
Sulindac—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000263	0.156	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000263	0.156	CbGdCrCtD
Sulindac—PTGS2—connective tissue—systemic lupus erythematosus	0.000262	0.00651	CbGeAlD
Sulindac—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000257	0.153	CbGdCrCtD
Sulindac—PTGS1—skin of body—systemic lupus erythematosus	0.000248	0.00615	CbGeAlD
Sulindac—PTGS2—skin of body—systemic lupus erythematosus	0.000237	0.00588	CbGeAlD
Sulindac—PTGS1—kidney—systemic lupus erythematosus	0.000234	0.0058	CbGeAlD
Sulindac—PTGS2—kidney—systemic lupus erythematosus	0.000223	0.00554	CbGeAlD
Sulindac—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000192	0.00476	CbGeAlD
Sulindac—CYP1A2—lung—systemic lupus erythematosus	0.000191	0.00474	CbGeAlD
Sulindac—PTGS1—tendon—systemic lupus erythematosus	0.000189	0.00468	CbGeAlD
Sulindac—CYP1A1—lung—systemic lupus erythematosus	0.000188	0.00468	CbGeAlD
Sulindac—PTGS2—tendon—systemic lupus erythematosus	0.00018	0.00447	CbGeAlD
Sulindac—PTGS2—bone marrow—systemic lupus erythematosus	0.000175	0.00433	CbGeAlD
Sulindac—CYP1A1—nervous system—systemic lupus erythematosus	0.000175	0.00433	CbGeAlD
Sulindac—CYP1A1—central nervous system—systemic lupus erythematosus	0.000168	0.00417	CbGeAlD
Sulindac—PTGS1—lung—systemic lupus erythematosus	0.000166	0.00411	CbGeAlD
Sulindac—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000161	0.0957	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000158	0.0942	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000158	0.0942	CbGdCrCtD
Sulindac—PTGS2—lung—systemic lupus erythematosus	0.000158	0.00393	CbGeAlD
Sulindac—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000155	0.0921	CbGdCrCtD
Sulindac—PTGS1—nervous system—systemic lupus erythematosus	0.000153	0.0038	CbGeAlD
Sulindac—PTGS1—central nervous system—systemic lupus erythematosus	0.000148	0.00366	CbGeAlD
Sulindac—PTGS2—nervous system—systemic lupus erythematosus	0.000147	0.00364	CbGeAlD
Sulindac—PTGS2—central nervous system—systemic lupus erythematosus	0.000141	0.0035	CbGeAlD
Sulindac—Epistaxis—Methotrexate—systemic lupus erythematosus	6.4e-05	0.00086	CcSEcCtD
Sulindac—Paraesthesia—Prednisolone—systemic lupus erythematosus	6.39e-05	0.000859	CcSEcCtD
Sulindac—Rash—Leflunomide—systemic lupus erythematosus	6.39e-05	0.000859	CcSEcCtD
Sulindac—Tachycardia—Triamcinolone—systemic lupus erythematosus	6.39e-05	0.000859	CcSEcCtD
Sulindac—Dermatitis—Leflunomide—systemic lupus erythematosus	6.39e-05	0.000859	CcSEcCtD
Sulindac—Nausea—Azathioprine—systemic lupus erythematosus	6.38e-05	0.000857	CcSEcCtD
Sulindac—Tachycardia—Methylprednisolone—systemic lupus erythematosus	6.38e-05	0.000857	CcSEcCtD
Sulindac—Headache—Leflunomide—systemic lupus erythematosus	6.35e-05	0.000854	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	6.34e-05	0.000852	CcSEcCtD
Sulindac—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	6.33e-05	0.000851	CcSEcCtD
Sulindac—Agranulocytosis—Methotrexate—systemic lupus erythematosus	6.33e-05	0.000851	CcSEcCtD
Sulindac—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	6.32e-05	0.000849	CcSEcCtD
Sulindac—Convulsion—Dexamethasone—systemic lupus erythematosus	6.31e-05	0.000848	CcSEcCtD
Sulindac—Convulsion—Betamethasone—systemic lupus erythematosus	6.31e-05	0.000848	CcSEcCtD
Sulindac—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	6.29e-05	0.000846	CcSEcCtD
Sulindac—Insomnia—Hydrocortisone—systemic lupus erythematosus	6.29e-05	0.000845	CcSEcCtD
Sulindac—Hypertension—Dexamethasone—systemic lupus erythematosus	6.29e-05	0.000845	CcSEcCtD
Sulindac—Hypertension—Betamethasone—systemic lupus erythematosus	6.29e-05	0.000845	CcSEcCtD
Sulindac—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	6.25e-05	0.000839	CcSEcCtD
Sulindac—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	6.24e-05	0.000839	CcSEcCtD
Sulindac—Urticaria—Cyclosporine—systemic lupus erythematosus	6.22e-05	0.000836	CcSEcCtD
Sulindac—Myalgia—Betamethasone—systemic lupus erythematosus	6.2e-05	0.000833	CcSEcCtD
Sulindac—Myalgia—Dexamethasone—systemic lupus erythematosus	6.2e-05	0.000833	CcSEcCtD
Sulindac—Body temperature increased—Cyclosporine—systemic lupus erythematosus	6.19e-05	0.000832	CcSEcCtD
Sulindac—Discomfort—Betamethasone—systemic lupus erythematosus	6.12e-05	0.000823	CcSEcCtD
Sulindac—Discomfort—Dexamethasone—systemic lupus erythematosus	6.12e-05	0.000823	CcSEcCtD
Sulindac—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	6.12e-05	0.000823	CcSEcCtD
Sulindac—Hypotension—Methylprednisolone—systemic lupus erythematosus	6.11e-05	0.000821	CcSEcCtD
Sulindac—Hepatitis—Methotrexate—systemic lupus erythematosus	6.09e-05	0.000818	CcSEcCtD
Sulindac—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	6.06e-05	0.000815	CcSEcCtD
Sulindac—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	6.05e-05	0.000813	CcSEcCtD
Sulindac—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	6.03e-05	0.000811	CcSEcCtD
Sulindac—Nausea—Leflunomide—systemic lupus erythematosus	6.02e-05	0.00081	CcSEcCtD
Sulindac—Fatigue—Hydrocortisone—systemic lupus erythematosus	6e-05	0.000806	CcSEcCtD
Sulindac—Vision blurred—Prednisone—systemic lupus erythematosus	5.98e-05	0.000803	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	5.97e-05	0.000802	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	5.95e-05	0.0008	CcSEcCtD
Sulindac—Oedema—Dexamethasone—systemic lupus erythematosus	5.94e-05	0.000799	CcSEcCtD
Sulindac—Oedema—Betamethasone—systemic lupus erythematosus	5.94e-05	0.000799	CcSEcCtD
Sulindac—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	5.94e-05	0.000799	CcSEcCtD
Sulindac—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	5.94e-05	0.000799	CcSEcCtD
Sulindac—Insomnia—Triamcinolone—systemic lupus erythematosus	5.92e-05	0.000796	CcSEcCtD
Sulindac—Insomnia—Methylprednisolone—systemic lupus erythematosus	5.91e-05	0.000794	CcSEcCtD
Sulindac—Ill-defined disorder—Prednisone—systemic lupus erythematosus	5.88e-05	0.000791	CcSEcCtD
Sulindac—Paraesthesia—Triamcinolone—systemic lupus erythematosus	5.88e-05	0.00079	CcSEcCtD
Sulindac—Feeling abnormal—Prednisolone—systemic lupus erythematosus	5.87e-05	0.000789	CcSEcCtD
Sulindac—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	5.87e-05	0.000789	CcSEcCtD
Sulindac—Visual impairment—Methotrexate—systemic lupus erythematosus	5.87e-05	0.000788	CcSEcCtD
Sulindac—Anaemia—Prednisone—systemic lupus erythematosus	5.86e-05	0.000788	CcSEcCtD
Sulindac—Shock—Dexamethasone—systemic lupus erythematosus	5.85e-05	0.000786	CcSEcCtD
Sulindac—Shock—Betamethasone—systemic lupus erythematosus	5.85e-05	0.000786	CcSEcCtD
Sulindac—Dyspnoea—Triamcinolone—systemic lupus erythematosus	5.84e-05	0.000785	CcSEcCtD
Sulindac—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	5.82e-05	0.000782	CcSEcCtD
Sulindac—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	5.82e-05	0.000782	CcSEcCtD
Sulindac—Tachycardia—Dexamethasone—systemic lupus erythematosus	5.8e-05	0.000779	CcSEcCtD
Sulindac—Tachycardia—Betamethasone—systemic lupus erythematosus	5.8e-05	0.000779	CcSEcCtD
Sulindac—Angioedema—Prednisone—systemic lupus erythematosus	5.79e-05	0.000779	CcSEcCtD
Sulindac—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	5.77e-05	0.000775	CcSEcCtD
Sulindac—Dyspepsia—Triamcinolone—systemic lupus erythematosus	5.76e-05	0.000775	CcSEcCtD
Sulindac—Erythema multiforme—Methotrexate—systemic lupus erythematosus	5.76e-05	0.000774	CcSEcCtD
Sulindac—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	5.75e-05	0.000773	CcSEcCtD
Sulindac—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	5.74e-05	0.000772	CcSEcCtD
Sulindac—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	5.74e-05	0.000772	CcSEcCtD
Sulindac—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	5.73e-05	0.00077	CcSEcCtD
Sulindac—Malaise—Prednisone—systemic lupus erythematosus	5.72e-05	0.000769	CcSEcCtD
Sulindac—Vertigo—Prednisone—systemic lupus erythematosus	5.7e-05	0.000766	CcSEcCtD
Sulindac—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	5.69e-05	0.000764	CcSEcCtD
Sulindac—Syncope—Prednisone—systemic lupus erythematosus	5.69e-05	0.000764	CcSEcCtD
Sulindac—Tinnitus—Methotrexate—systemic lupus erythematosus	5.68e-05	0.000763	CcSEcCtD
Sulindac—Anorexia—Betamethasone—systemic lupus erythematosus	5.66e-05	0.000761	CcSEcCtD
Sulindac—Anorexia—Dexamethasone—systemic lupus erythematosus	5.66e-05	0.000761	CcSEcCtD
Sulindac—Urticaria—Prednisolone—systemic lupus erythematosus	5.66e-05	0.00076	CcSEcCtD
Sulindac—Fatigue—Triamcinolone—systemic lupus erythematosus	5.65e-05	0.000759	CcSEcCtD
Sulindac—Fatigue—Methylprednisolone—systemic lupus erythematosus	5.63e-05	0.000757	CcSEcCtD
Sulindac—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	5.62e-05	0.000756	CcSEcCtD
Sulindac—Asthenia—Cyclosporine—systemic lupus erythematosus	5.61e-05	0.000755	CcSEcCtD
Sulindac—Loss of consciousness—Prednisone—systemic lupus erythematosus	5.57e-05	0.000749	CcSEcCtD
Sulindac—Hypotension—Dexamethasone—systemic lupus erythematosus	5.55e-05	0.000746	CcSEcCtD
Sulindac—Hypotension—Betamethasone—systemic lupus erythematosus	5.55e-05	0.000746	CcSEcCtD
Sulindac—Pruritus—Cyclosporine—systemic lupus erythematosus	5.54e-05	0.000744	CcSEcCtD
Sulindac—Urticaria—Hydrocortisone—systemic lupus erythematosus	5.53e-05	0.000743	CcSEcCtD
Sulindac—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	5.5e-05	0.000739	CcSEcCtD
Sulindac—Convulsion—Prednisone—systemic lupus erythematosus	5.49e-05	0.000738	CcSEcCtD
Sulindac—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	5.48e-05	0.000736	CcSEcCtD
Sulindac—Hypertension—Prednisone—systemic lupus erythematosus	5.47e-05	0.000736	CcSEcCtD
Sulindac—Chills—Methotrexate—systemic lupus erythematosus	5.46e-05	0.000734	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	5.41e-05	0.000728	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	5.41e-05	0.000728	CcSEcCtD
Sulindac—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	5.4e-05	0.000726	CcSEcCtD
Sulindac—Myalgia—Prednisone—systemic lupus erythematosus	5.4e-05	0.000726	CcSEcCtD
Sulindac—Arthralgia—Prednisone—systemic lupus erythematosus	5.4e-05	0.000726	CcSEcCtD
Sulindac—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	5.4e-05	0.000725	CcSEcCtD
Sulindac—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	5.38e-05	0.000724	CcSEcCtD
Sulindac—Alopecia—Methotrexate—systemic lupus erythematosus	5.38e-05	0.000723	CcSEcCtD
Sulindac—Insomnia—Dexamethasone—systemic lupus erythematosus	5.37e-05	0.000722	CcSEcCtD
Sulindac—Insomnia—Betamethasone—systemic lupus erythematosus	5.37e-05	0.000722	CcSEcCtD
Sulindac—Diarrhoea—Cyclosporine—systemic lupus erythematosus	5.35e-05	0.00072	CcSEcCtD
Sulindac—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	5.34e-05	0.000718	CcSEcCtD
Sulindac—Paraesthesia—Betamethasone—systemic lupus erythematosus	5.34e-05	0.000717	CcSEcCtD
Sulindac—Paraesthesia—Dexamethasone—systemic lupus erythematosus	5.34e-05	0.000717	CcSEcCtD
Sulindac—Discomfort—Prednisone—systemic lupus erythematosus	5.33e-05	0.000717	CcSEcCtD
Sulindac—Hypersensitivity—Prednisolone—systemic lupus erythematosus	5.25e-05	0.000705	CcSEcCtD
Sulindac—Dyspepsia—Betamethasone—systemic lupus erythematosus	5.23e-05	0.000703	CcSEcCtD
Sulindac—Dyspepsia—Dexamethasone—systemic lupus erythematosus	5.23e-05	0.000703	CcSEcCtD
Sulindac—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	5.22e-05	0.000702	CcSEcCtD
Sulindac—Urticaria—Triamcinolone—systemic lupus erythematosus	5.2e-05	0.000699	CcSEcCtD
Sulindac—Urticaria—Methylprednisolone—systemic lupus erythematosus	5.19e-05	0.000698	CcSEcCtD
Sulindac—Dysgeusia—Methotrexate—systemic lupus erythematosus	5.19e-05	0.000697	CcSEcCtD
Sulindac—Body temperature increased—Triamcinolone—systemic lupus erythematosus	5.18e-05	0.000696	CcSEcCtD
Sulindac—Dizziness—Cyclosporine—systemic lupus erythematosus	5.17e-05	0.000696	CcSEcCtD
Sulindac—Anaphylactic shock—Prednisone—systemic lupus erythematosus	5.17e-05	0.000696	CcSEcCtD
Sulindac—Oedema—Prednisone—systemic lupus erythematosus	5.17e-05	0.000696	CcSEcCtD
Sulindac—Decreased appetite—Dexamethasone—systemic lupus erythematosus	5.17e-05	0.000694	CcSEcCtD
Sulindac—Decreased appetite—Betamethasone—systemic lupus erythematosus	5.17e-05	0.000694	CcSEcCtD
Sulindac—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	5.12e-05	0.000689	CcSEcCtD
Sulindac—Fatigue—Dexamethasone—systemic lupus erythematosus	5.12e-05	0.000689	CcSEcCtD
Sulindac—Fatigue—Betamethasone—systemic lupus erythematosus	5.12e-05	0.000689	CcSEcCtD
Sulindac—Shock—Prednisone—systemic lupus erythematosus	5.09e-05	0.000684	CcSEcCtD
Sulindac—Tachycardia—Prednisone—systemic lupus erythematosus	5.05e-05	0.000679	CcSEcCtD
Sulindac—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	5.05e-05	0.000679	CcSEcCtD
Sulindac—Hyperhidrosis—Prednisone—systemic lupus erythematosus	5e-05	0.000672	CcSEcCtD
Sulindac—Vision blurred—Methotrexate—systemic lupus erythematosus	4.99e-05	0.000671	CcSEcCtD
Sulindac—Asthenia—Hydrocortisone—systemic lupus erythematosus	4.99e-05	0.000671	CcSEcCtD
Sulindac—Vomiting—Cyclosporine—systemic lupus erythematosus	4.98e-05	0.000669	CcSEcCtD
Sulindac—Rash—Cyclosporine—systemic lupus erythematosus	4.93e-05	0.000663	CcSEcCtD
Sulindac—Anorexia—Prednisone—systemic lupus erythematosus	4.93e-05	0.000663	CcSEcCtD
Sulindac—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.93e-05	0.000663	CcSEcCtD
Sulindac—Pruritus—Hydrocortisone—systemic lupus erythematosus	4.92e-05	0.000661	CcSEcCtD
Sulindac—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	4.92e-05	0.000661	CcSEcCtD
Sulindac—Headache—Cyclosporine—systemic lupus erythematosus	4.9e-05	0.000659	CcSEcCtD
Sulindac—Anaemia—Methotrexate—systemic lupus erythematosus	4.9e-05	0.000658	CcSEcCtD
Sulindac—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	4.9e-05	0.000658	CcSEcCtD
Sulindac—Feeling abnormal—Betamethasone—systemic lupus erythematosus	4.9e-05	0.000658	CcSEcCtD
Sulindac—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	4.86e-05	0.000653	CcSEcCtD
Sulindac—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	4.86e-05	0.000653	CcSEcCtD
Sulindac—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	4.85e-05	0.000652	CcSEcCtD
Sulindac—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	4.82e-05	0.000649	CcSEcCtD
Sulindac—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	4.81e-05	0.000647	CcSEcCtD
Sulindac—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4.81e-05	0.000647	CcSEcCtD
Sulindac—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	4.81e-05	0.000646	CcSEcCtD
Sulindac—Headache—Mycophenolate mofetil—systemic lupus erythematosus	4.78e-05	0.000643	CcSEcCtD
Sulindac—Malaise—Methotrexate—systemic lupus erythematosus	4.78e-05	0.000642	CcSEcCtD
Sulindac—Vertigo—Methotrexate—systemic lupus erythematosus	4.76e-05	0.00064	CcSEcCtD
Sulindac—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	4.76e-05	0.00064	CcSEcCtD
Sulindac—Leukopenia—Methotrexate—systemic lupus erythematosus	4.74e-05	0.000638	CcSEcCtD
Sulindac—Urticaria—Dexamethasone—systemic lupus erythematosus	4.72e-05	0.000634	CcSEcCtD
Sulindac—Urticaria—Betamethasone—systemic lupus erythematosus	4.72e-05	0.000634	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	4.71e-05	0.000634	CcSEcCtD
Sulindac—Dizziness—Prednisolone—systemic lupus erythematosus	4.71e-05	0.000633	CcSEcCtD
Sulindac—Asthenia—Triamcinolone—systemic lupus erythematosus	4.7e-05	0.000632	CcSEcCtD
Sulindac—Body temperature increased—Betamethasone—systemic lupus erythematosus	4.7e-05	0.000631	CcSEcCtD
Sulindac—Body temperature increased—Dexamethasone—systemic lupus erythematosus	4.7e-05	0.000631	CcSEcCtD
Sulindac—Asthenia—Methylprednisolone—systemic lupus erythematosus	4.69e-05	0.00063	CcSEcCtD
Sulindac—Insomnia—Prednisone—systemic lupus erythematosus	4.68e-05	0.000629	CcSEcCtD
Sulindac—Nausea—Cyclosporine—systemic lupus erythematosus	4.65e-05	0.000625	CcSEcCtD
Sulindac—Paraesthesia—Prednisone—systemic lupus erythematosus	4.65e-05	0.000625	CcSEcCtD
Sulindac—Pruritus—Triamcinolone—systemic lupus erythematosus	4.63e-05	0.000623	CcSEcCtD
Sulindac—Pruritus—Methylprednisolone—systemic lupus erythematosus	4.62e-05	0.000621	CcSEcCtD
Sulindac—Dizziness—Hydrocortisone—systemic lupus erythematosus	4.6e-05	0.000618	CcSEcCtD
Sulindac—Convulsion—Methotrexate—systemic lupus erythematosus	4.59e-05	0.000617	CcSEcCtD
Sulindac—Dyspepsia—Prednisone—systemic lupus erythematosus	4.56e-05	0.000612	CcSEcCtD
Sulindac—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	4.53e-05	0.000609	CcSEcCtD
Sulindac—Myalgia—Methotrexate—systemic lupus erythematosus	4.51e-05	0.000606	CcSEcCtD
Sulindac—Chest pain—Methotrexate—systemic lupus erythematosus	4.51e-05	0.000606	CcSEcCtD
Sulindac—Arthralgia—Methotrexate—systemic lupus erythematosus	4.51e-05	0.000606	CcSEcCtD
Sulindac—Decreased appetite—Prednisone—systemic lupus erythematosus	4.5e-05	0.000605	CcSEcCtD
Sulindac—Rash—Prednisolone—systemic lupus erythematosus	4.49e-05	0.000604	CcSEcCtD
Sulindac—Dermatitis—Prednisolone—systemic lupus erythematosus	4.49e-05	0.000603	CcSEcCtD
Sulindac—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	4.47e-05	0.000601	CcSEcCtD
Sulindac—Fatigue—Prednisone—systemic lupus erythematosus	4.46e-05	0.0006	CcSEcCtD
Sulindac—Headache—Prednisolone—systemic lupus erythematosus	4.46e-05	0.0006	CcSEcCtD
Sulindac—Discomfort—Methotrexate—systemic lupus erythematosus	4.46e-05	0.000599	CcSEcCtD
Sulindac—Constipation—Prednisone—systemic lupus erythematosus	4.43e-05	0.000595	CcSEcCtD
Sulindac—Vomiting—Hydrocortisone—systemic lupus erythematosus	4.42e-05	0.000594	CcSEcCtD
Sulindac—Rash—Hydrocortisone—systemic lupus erythematosus	4.39e-05	0.000589	CcSEcCtD
Sulindac—Dermatitis—Hydrocortisone—systemic lupus erythematosus	4.38e-05	0.000589	CcSEcCtD
Sulindac—Headache—Hydrocortisone—systemic lupus erythematosus	4.36e-05	0.000586	CcSEcCtD
Sulindac—Dizziness—Triamcinolone—systemic lupus erythematosus	4.33e-05	0.000582	CcSEcCtD
Sulindac—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	4.32e-05	0.000581	CcSEcCtD
Sulindac—Dizziness—Methylprednisolone—systemic lupus erythematosus	4.32e-05	0.000581	CcSEcCtD
Sulindac—Feeling abnormal—Prednisone—systemic lupus erythematosus	4.26e-05	0.000573	CcSEcCtD
Sulindac—Asthenia—Dexamethasone—systemic lupus erythematosus	4.26e-05	0.000573	CcSEcCtD
Sulindac—Asthenia—Betamethasone—systemic lupus erythematosus	4.26e-05	0.000573	CcSEcCtD
Sulindac—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	4.23e-05	0.000569	CcSEcCtD
Sulindac—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	4.23e-05	0.000569	CcSEcCtD
Sulindac—Nausea—Prednisolone—systemic lupus erythematosus	4.23e-05	0.000569	CcSEcCtD
Sulindac—Pruritus—Betamethasone—systemic lupus erythematosus	4.2e-05	0.000565	CcSEcCtD
Sulindac—Pruritus—Dexamethasone—systemic lupus erythematosus	4.2e-05	0.000565	CcSEcCtD
Sulindac—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	4.18e-05	0.000562	CcSEcCtD
Sulindac—Vomiting—Triamcinolone—systemic lupus erythematosus	4.16e-05	0.00056	CcSEcCtD
Sulindac—Vomiting—Methylprednisolone—systemic lupus erythematosus	4.15e-05	0.000558	CcSEcCtD
Sulindac—Nausea—Hydrocortisone—systemic lupus erythematosus	4.13e-05	0.000555	CcSEcCtD
Sulindac—Rash—Triamcinolone—systemic lupus erythematosus	4.13e-05	0.000555	CcSEcCtD
Sulindac—Dermatitis—Triamcinolone—systemic lupus erythematosus	4.13e-05	0.000554	CcSEcCtD
Sulindac—Anorexia—Methotrexate—systemic lupus erythematosus	4.12e-05	0.000554	CcSEcCtD
Sulindac—Rash—Methylprednisolone—systemic lupus erythematosus	4.12e-05	0.000554	CcSEcCtD
Sulindac—Dermatitis—Methylprednisolone—systemic lupus erythematosus	4.12e-05	0.000553	CcSEcCtD
Sulindac—Urticaria—Prednisone—systemic lupus erythematosus	4.11e-05	0.000553	CcSEcCtD
Sulindac—Headache—Triamcinolone—systemic lupus erythematosus	4.1e-05	0.000551	CcSEcCtD
Sulindac—Headache—Methylprednisolone—systemic lupus erythematosus	4.09e-05	0.00055	CcSEcCtD
Sulindac—Body temperature increased—Prednisone—systemic lupus erythematosus	4.09e-05	0.00055	CcSEcCtD
Sulindac—Diarrhoea—Dexamethasone—systemic lupus erythematosus	4.07e-05	0.000546	CcSEcCtD
Sulindac—Diarrhoea—Betamethasone—systemic lupus erythematosus	4.07e-05	0.000546	CcSEcCtD
Sulindac—Hypotension—Methotrexate—systemic lupus erythematosus	4.04e-05	0.000543	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.94e-05	0.00053	CcSEcCtD
Sulindac—Dizziness—Dexamethasone—systemic lupus erythematosus	3.93e-05	0.000528	CcSEcCtD
Sulindac—Dizziness—Betamethasone—systemic lupus erythematosus	3.93e-05	0.000528	CcSEcCtD
Sulindac—Insomnia—Methotrexate—systemic lupus erythematosus	3.91e-05	0.000526	CcSEcCtD
Sulindac—Nausea—Triamcinolone—systemic lupus erythematosus	3.89e-05	0.000523	CcSEcCtD
Sulindac—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.88e-05	0.000522	CcSEcCtD
Sulindac—Nausea—Methylprednisolone—systemic lupus erythematosus	3.88e-05	0.000522	CcSEcCtD
Sulindac—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.86e-05	0.000518	CcSEcCtD
Sulindac—Somnolence—Methotrexate—systemic lupus erythematosus	3.84e-05	0.000517	CcSEcCtD
Sulindac—Hypersensitivity—Prednisone—systemic lupus erythematosus	3.81e-05	0.000512	CcSEcCtD
Sulindac—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.81e-05	0.000512	CcSEcCtD
Sulindac—Vomiting—Dexamethasone—systemic lupus erythematosus	3.78e-05	0.000508	CcSEcCtD
Sulindac—Vomiting—Betamethasone—systemic lupus erythematosus	3.78e-05	0.000508	CcSEcCtD
Sulindac—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.76e-05	0.000505	CcSEcCtD
Sulindac—Rash—Dexamethasone—systemic lupus erythematosus	3.75e-05	0.000504	CcSEcCtD
Sulindac—Rash—Betamethasone—systemic lupus erythematosus	3.75e-05	0.000504	CcSEcCtD
Sulindac—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.74e-05	0.000503	CcSEcCtD
Sulindac—Dermatitis—Betamethasone—systemic lupus erythematosus	3.74e-05	0.000503	CcSEcCtD
Sulindac—Fatigue—Methotrexate—systemic lupus erythematosus	3.73e-05	0.000501	CcSEcCtD
Sulindac—Headache—Betamethasone—systemic lupus erythematosus	3.72e-05	0.0005	CcSEcCtD
Sulindac—Headache—Dexamethasone—systemic lupus erythematosus	3.72e-05	0.0005	CcSEcCtD
Sulindac—Asthenia—Prednisone—systemic lupus erythematosus	3.71e-05	0.000499	CcSEcCtD
Sulindac—Pruritus—Prednisone—systemic lupus erythematosus	3.66e-05	0.000492	CcSEcCtD
Sulindac—Feeling abnormal—Methotrexate—systemic lupus erythematosus	3.56e-05	0.000479	CcSEcCtD
Sulindac—Diarrhoea—Prednisone—systemic lupus erythematosus	3.54e-05	0.000476	CcSEcCtD
Sulindac—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.54e-05	0.000475	CcSEcCtD
Sulindac—Nausea—Betamethasone—systemic lupus erythematosus	3.53e-05	0.000474	CcSEcCtD
Sulindac—Nausea—Dexamethasone—systemic lupus erythematosus	3.53e-05	0.000474	CcSEcCtD
Sulindac—Urticaria—Methotrexate—systemic lupus erythematosus	3.44e-05	0.000462	CcSEcCtD
Sulindac—Dizziness—Prednisone—systemic lupus erythematosus	3.42e-05	0.00046	CcSEcCtD
Sulindac—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.42e-05	0.00046	CcSEcCtD
Sulindac—Vomiting—Prednisone—systemic lupus erythematosus	3.29e-05	0.000442	CcSEcCtD
Sulindac—Rash—Prednisone—systemic lupus erythematosus	3.26e-05	0.000439	CcSEcCtD
Sulindac—Dermatitis—Prednisone—systemic lupus erythematosus	3.26e-05	0.000438	CcSEcCtD
Sulindac—Headache—Prednisone—systemic lupus erythematosus	3.24e-05	0.000436	CcSEcCtD
Sulindac—Hypersensitivity—Methotrexate—systemic lupus erythematosus	3.19e-05	0.000428	CcSEcCtD
Sulindac—Asthenia—Methotrexate—systemic lupus erythematosus	3.1e-05	0.000417	CcSEcCtD
Sulindac—Nausea—Prednisone—systemic lupus erythematosus	3.07e-05	0.000413	CcSEcCtD
Sulindac—Pruritus—Methotrexate—systemic lupus erythematosus	3.06e-05	0.000411	CcSEcCtD
Sulindac—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.96e-05	0.000398	CcSEcCtD
Sulindac—Dizziness—Methotrexate—systemic lupus erythematosus	2.86e-05	0.000384	CcSEcCtD
Sulindac—Vomiting—Methotrexate—systemic lupus erythematosus	2.75e-05	0.00037	CcSEcCtD
Sulindac—Rash—Methotrexate—systemic lupus erythematosus	2.73e-05	0.000367	CcSEcCtD
Sulindac—Dermatitis—Methotrexate—systemic lupus erythematosus	2.72e-05	0.000366	CcSEcCtD
Sulindac—Headache—Methotrexate—systemic lupus erythematosus	2.71e-05	0.000364	CcSEcCtD
Sulindac—Nausea—Methotrexate—systemic lupus erythematosus	2.57e-05	0.000345	CcSEcCtD
Sulindac—MAPK3—DAP12 signaling—IL6—systemic lupus erythematosus	1.27e-05	0.000164	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL6—systemic lupus erythematosus	1.27e-05	0.000164	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—VEGFA—systemic lupus erythematosus	1.26e-05	0.000162	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.25e-05	0.000161	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.25e-05	0.000161	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.24e-05	0.000161	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PTPRC—systemic lupus erythematosus	1.24e-05	0.00016	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1RN—systemic lupus erythematosus	1.23e-05	0.000159	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—PPARG—systemic lupus erythematosus	1.23e-05	0.000159	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—PPARG—systemic lupus erythematosus	1.23e-05	0.000158	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.22e-05	0.000158	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—TLR4—systemic lupus erythematosus	1.22e-05	0.000157	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	1.22e-05	0.000157	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	1.22e-05	0.000157	CbGpPWpGaD
Sulindac—PTGS2—Disease—XRCC6—systemic lupus erythematosus	1.22e-05	0.000157	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—IL6—systemic lupus erythematosus	1.2e-05	0.000154	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	1.2e-05	0.000154	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—IL6—systemic lupus erythematosus	1.2e-05	0.000154	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—MMP9—systemic lupus erythematosus	1.19e-05	0.000153	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.19e-05	0.000153	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—IL6—systemic lupus erythematosus	1.19e-05	0.000153	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—IL6—systemic lupus erythematosus	1.18e-05	0.000152	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—IL6—systemic lupus erythematosus	1.17e-05	0.000151	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.16e-05	0.00015	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TLR9—systemic lupus erythematosus	1.15e-05	0.000149	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD40—systemic lupus erythematosus	1.15e-05	0.000148	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—IL6—systemic lupus erythematosus	1.15e-05	0.000148	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—JUNB—systemic lupus erythematosus	1.14e-05	0.000146	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CTLA4—systemic lupus erythematosus	1.13e-05	0.000146	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HMGB1—systemic lupus erythematosus	1.13e-05	0.000146	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD80—systemic lupus erythematosus	1.13e-05	0.000145	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.12e-05	0.000144	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IFNA1—systemic lupus erythematosus	1.11e-05	0.000144	CbGpPWpGaD
Sulindac—MAPK3—Immune System—RASGRP1—systemic lupus erythematosus	1.09e-05	0.00014	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—ALB—systemic lupus erythematosus	1.08e-05	0.00014	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD79A—systemic lupus erythematosus	1.08e-05	0.00014	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TYK2—systemic lupus erythematosus	1.08e-05	0.000139	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.07e-05	0.000139	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—VEGFA—systemic lupus erythematosus	1.07e-05	0.000138	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.06e-05	0.000137	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	1.06e-05	0.000137	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.06e-05	0.000136	CbGpPWpGaD
Sulindac—MAPK3—Disease—JUNB—systemic lupus erythematosus	1.05e-05	0.000136	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PRL—systemic lupus erythematosus	1.05e-05	0.000136	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL2—systemic lupus erythematosus	1.04e-05	0.000134	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—NOS3—systemic lupus erythematosus	1.04e-05	0.000134	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	1.03e-05	0.000133	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.03e-05	0.000133	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL6—systemic lupus erythematosus	1.03e-05	0.000133	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CSK—systemic lupus erythematosus	1.03e-05	0.000133	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	1.02e-05	0.000132	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IFNA1—systemic lupus erythematosus	1.02e-05	0.000132	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.02e-05	0.000132	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.01e-05	0.00013	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DQA1—systemic lupus erythematosus	9.98e-06	0.000129	CbGpPWpGaD
Sulindac—ALB—Hemostasis—RASGRP1—systemic lupus erythematosus	9.96e-06	0.000128	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—RXRA—systemic lupus erythematosus	9.95e-06	0.000128	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	9.85e-06	0.000127	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MMP9—systemic lupus erythematosus	9.83e-06	0.000127	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.79e-06	0.000126	CbGpPWpGaD
Sulindac—MAPK3—Disease—PRL—systemic lupus erythematosus	9.72e-06	0.000125	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	9.68e-06	0.000125	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PPARG—systemic lupus erythematosus	9.57e-06	0.000123	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	9.52e-06	0.000123	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—TYK2—systemic lupus erythematosus	9.51e-06	0.000123	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	9.48e-06	0.000122	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NCF2—systemic lupus erythematosus	9.41e-06	0.000121	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LYN—systemic lupus erythematosus	9.35e-06	0.000121	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DQB1—systemic lupus erythematosus	9.34e-06	0.00012	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—EP300—systemic lupus erythematosus	9.32e-06	0.00012	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—JAK1—systemic lupus erythematosus	9.21e-06	0.000119	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.17e-06	0.000118	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.17e-06	0.000118	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—VDR—systemic lupus erythematosus	9.01e-06	0.000116	CbGpPWpGaD
Sulindac—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	8.97e-06	0.000116	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	8.89e-06	0.000115	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL18—systemic lupus erythematosus	8.85e-06	0.000114	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.82e-06	0.000114	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD40LG—systemic lupus erythematosus	8.82e-06	0.000114	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IL2—systemic lupus erythematosus	8.79e-06	0.000113	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	8.75e-06	0.000113	CbGpPWpGaD
Sulindac—PTGS2—Disease—CSK—systemic lupus erythematosus	8.74e-06	0.000113	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCR5—systemic lupus erythematosus	8.73e-06	0.000113	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD8A—systemic lupus erythematosus	8.72e-06	0.000112	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—IL6—systemic lupus erythematosus	8.69e-06	0.000112	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.68e-06	0.000112	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ALB—systemic lupus erythematosus	8.61e-06	0.000111	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.6e-06	0.000111	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD4—systemic lupus erythematosus	8.6e-06	0.000111	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—C3—systemic lupus erythematosus	8.53e-06	0.00011	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—MMP9—systemic lupus erythematosus	8.48e-06	0.000109	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CDKN1B—systemic lupus erythematosus	8.47e-06	0.000109	CbGpPWpGaD
Sulindac—MAPK3—Immune System—JAK1—systemic lupus erythematosus	8.42e-06	0.000109	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.36e-06	0.000108	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	8.32e-06	0.000107	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	8.3e-06	0.000107	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL6—systemic lupus erythematosus	8.29e-06	0.000107	CbGpPWpGaD
Sulindac—PPARD—Metabolism—NOS3—systemic lupus erythematosus	8.23e-06	0.000106	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.22e-06	0.000106	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD247—systemic lupus erythematosus	8.22e-06	0.000106	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	8.21e-06	0.000106	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	8.2e-06	0.000106	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—IL6—systemic lupus erythematosus	8.15e-06	0.000105	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NR3C1—systemic lupus erythematosus	8.11e-06	0.000105	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TGFB1—systemic lupus erythematosus	8.1e-06	0.000104	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CDKN1B—systemic lupus erythematosus	8.08e-06	0.000104	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—EP300—systemic lupus erythematosus	8.04e-06	0.000104	CbGpPWpGaD
Sulindac—PTGS2—Disease—NCF2—systemic lupus erythematosus	7.99e-06	0.000103	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	7.95e-06	0.000103	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—EP300—systemic lupus erythematosus	7.89e-06	0.000102	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL2RA—systemic lupus erythematosus	7.86e-06	0.000101	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CDKN1A—systemic lupus erythematosus	7.82e-06	0.000101	CbGpPWpGaD
Sulindac—MAPK3—Immune System—C3—systemic lupus erythematosus	7.79e-06	0.000101	CbGpPWpGaD
Sulindac—MAPK3—Disease—JAK1—systemic lupus erythematosus	7.77e-06	0.0001	CbGpPWpGaD
Sulindac—ALB—Hemostasis—JAK1—systemic lupus erythematosus	7.72e-06	9.96e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—VEGFA—systemic lupus erythematosus	7.61e-06	9.82e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PTGS2—systemic lupus erythematosus	7.53e-06	9.71e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.52e-06	9.7e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—F2—systemic lupus erythematosus	7.49e-06	9.66e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—VEGFA—systemic lupus erythematosus	7.47e-06	9.63e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CDKN1A—systemic lupus erythematosus	7.46e-06	9.62e-05	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—EP300—systemic lupus erythematosus	7.44e-06	9.6e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CRP—systemic lupus erythematosus	7.41e-06	9.56e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.39e-06	9.53e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—JUNB—systemic lupus erythematosus	7.38e-06	9.52e-05	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—IL6—systemic lupus erythematosus	7.38e-06	9.52e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CCR5—systemic lupus erythematosus	7.36e-06	9.5e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NAT2—systemic lupus erythematosus	7.29e-06	9.4e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	7.21e-06	9.3e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TLR4—systemic lupus erythematosus	7.11e-06	9.17e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DRB1—systemic lupus erythematosus	7.1e-06	9.16e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—EP300—systemic lupus erythematosus	7.1e-06	9.16e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.02e-06	9.05e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TGFB1—systemic lupus erythematosus	6.99e-06	9.01e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	6.97e-06	8.99e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TGFB1—systemic lupus erythematosus	6.86e-06	8.84e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PRL—systemic lupus erythematosus	6.8e-06	8.77e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.68e-06	8.61e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NAT2—systemic lupus erythematosus	6.64e-06	8.57e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD80—systemic lupus erythematosus	6.56e-06	8.46e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.53e-06	8.42e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—systemic lupus erythematosus	6.53e-06	8.41e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.47e-06	8.34e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	6.4e-06	8.25e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—PPARG—systemic lupus erythematosus	6.28e-06	8.1e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—F2—systemic lupus erythematosus	6.28e-06	8.1e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—JUNB—systemic lupus erythematosus	6.27e-06	8.09e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—EP300—systemic lupus erythematosus	6.26e-06	8.08e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL6—systemic lupus erythematosus	6.1e-06	7.87e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.06e-06	7.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD80—systemic lupus erythematosus	6.06e-06	7.81e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.87e-06	7.57e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.85e-06	7.54e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	5.8e-06	7.48e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.79e-06	7.47e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PRL—systemic lupus erythematosus	5.78e-06	7.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TYK2—systemic lupus erythematosus	5.54e-06	7.14e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—JAK1—systemic lupus erythematosus	5.44e-06	7.02e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.38e-06	6.94e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.28e-06	6.81e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—IL6—systemic lupus erythematosus	5.27e-06	6.79e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.21e-06	6.72e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IFNG—systemic lupus erythematosus	5.19e-06	6.69e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCR5—systemic lupus erythematosus	5.16e-06	6.65e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—TYK2—systemic lupus erythematosus	5.11e-06	6.59e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.08e-06	6.55e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL2—systemic lupus erythematosus	5.04e-06	6.5e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—C3—systemic lupus erythematosus	5.04e-06	6.5e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS3—systemic lupus erythematosus	5.02e-06	6.47e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD4—systemic lupus erythematosus	5.01e-06	6.46e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS3—systemic lupus erythematosus	4.99e-06	6.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CDKN1B—systemic lupus erythematosus	4.71e-06	6.07e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—systemic lupus erythematosus	4.65e-06	6e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	4.65e-06	5.99e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD4—systemic lupus erythematosus	4.62e-06	5.96e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—JAK1—systemic lupus erythematosus	4.62e-06	5.96e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL2—systemic lupus erythematosus	4.61e-06	5.94e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	4.6e-06	5.94e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTGS2—systemic lupus erythematosus	4.59e-06	5.92e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.56e-06	5.88e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—F2—systemic lupus erythematosus	4.42e-06	5.71e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CCR5—systemic lupus erythematosus	4.38e-06	5.65e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CDKN1B—systemic lupus erythematosus	4.35e-06	5.61e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CDKN1A—systemic lupus erythematosus	4.35e-06	5.6e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.27e-06	5.51e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CD80—systemic lupus erythematosus	4.24e-06	5.47e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL2—systemic lupus erythematosus	4.23e-06	5.45e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.15e-06	5.36e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—EP300—systemic lupus erythematosus	4.13e-06	5.33e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	4.09e-06	5.27e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CDKN1A—systemic lupus erythematosus	4.01e-06	5.17e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL2—systemic lupus erythematosus	3.94e-06	5.09e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—EP300—systemic lupus erythematosus	3.82e-06	4.92e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—EP300—systemic lupus erythematosus	3.79e-06	4.89e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.79e-06	4.89e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—RXRA—systemic lupus erythematosus	3.72e-06	4.8e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.69e-06	4.76e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	3.66e-06	4.72e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD80—systemic lupus erythematosus	3.6e-06	4.65e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	3.59e-06	4.63e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TYK2—systemic lupus erythematosus	3.58e-06	4.62e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—systemic lupus erythematosus	3.51e-06	4.53e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.45e-06	4.45e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.32e-06	4.28e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—TGFB1—systemic lupus erythematosus	3.32e-06	4.28e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	3.3e-06	4.25e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALB—systemic lupus erythematosus	3.29e-06	4.25e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	3.15e-06	4.06e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.04e-06	3.93e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TYK2—systemic lupus erythematosus	3.04e-06	3.92e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—systemic lupus erythematosus	2.98e-06	3.85e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL2—systemic lupus erythematosus	2.98e-06	3.84e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—systemic lupus erythematosus	2.96e-06	3.82e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	2.91e-06	3.75e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.9e-06	3.75e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	2.88e-06	3.71e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MMP9—systemic lupus erythematosus	2.82e-06	3.64e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.81e-06	3.62e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD4—systemic lupus erythematosus	2.75e-06	3.55e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—systemic lupus erythematosus	2.71e-06	3.49e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EP300—systemic lupus erythematosus	2.67e-06	3.45e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALB—systemic lupus erythematosus	2.61e-06	3.37e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	2.6e-06	3.36e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	2.59e-06	3.33e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	2.58e-06	3.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.53e-06	3.27e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—systemic lupus erythematosus	2.5e-06	3.23e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	2.5e-06	3.22e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.42e-06	3.12e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—EP300—systemic lupus erythematosus	2.4e-06	3.09e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	2.39e-06	3.08e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARG—systemic lupus erythematosus	2.35e-06	3.03e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.32e-06	3e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	2.32e-06	2.99e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—EP300—systemic lupus erythematosus	2.27e-06	2.93e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	2.22e-06	2.86e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	2.03e-06	2.62e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—systemic lupus erythematosus	2.02e-06	2.61e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TGFB1—systemic lupus erythematosus	1.97e-06	2.55e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—EP300—systemic lupus erythematosus	1.9e-06	2.45e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS2—systemic lupus erythematosus	1.85e-06	2.39e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—systemic lupus erythematosus	1.75e-06	2.26e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	1.69e-06	2.18e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	1.64e-06	2.12e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—EP300—systemic lupus erythematosus	1.54e-06	1.98e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—systemic lupus erythematosus	1.49e-06	1.92e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	1.48e-06	1.91e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	1.41e-06	1.82e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.29e-06	1.67e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.08e-06	1.39e-05	CbGpPWpGaD
